Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S0074-02762010000500015 http://repositorio.unifesp.br/handle/11600/5853 |
Resumo: | The potential use of the Trypanosoma cruzi metacyclic trypomastigote (MT) stage-specific molecule glycoprotein-82 (gp82) as a vaccine target has not been fully explored. We show that the opsonization of T. cruzi MT with gp82-specific antibody prior to mucosal challenge significantly reduces parasite infectivity. In addition, we investigated the immune responses as well as the systemic and mucosal protective immunity induced by intranasal CpG-adjuvanted gp82 vaccination. Spleen cells from mice immunized with CpG-gp82 proliferated and secreted IFN-γ in a dose-dependent manner in response to in vitro stimulation with gp82 and parasite lysate. More importantly, these CpG-gp82-immunized mice were significantly protected from a biologically relevant oral parasite challenge. |
id |
UFSP_d0fbe26c10f433b86f41fd76993c95e3 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/5853 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infectionTrypanosoma cruzimucosal immunityvaccinesThe potential use of the Trypanosoma cruzi metacyclic trypomastigote (MT) stage-specific molecule glycoprotein-82 (gp82) as a vaccine target has not been fully explored. We show that the opsonization of T. cruzi MT with gp82-specific antibody prior to mucosal challenge significantly reduces parasite infectivity. In addition, we investigated the immune responses as well as the systemic and mucosal protective immunity induced by intranasal CpG-adjuvanted gp82 vaccination. Spleen cells from mice immunized with CpG-gp82 proliferated and secreted IFN-γ in a dose-dependent manner in response to in vitro stimulation with gp82 and parasite lysate. More importantly, these CpG-gp82-immunized mice were significantly protected from a biologically relevant oral parasite challenge.Saint Louis University Department of Molecular MicrobiologyUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de Microbiologia, Imunologia e ParasitologiaUNIFESP, EPM, Depto. de Microbiologia, Imunologia e ParasitologiaSciELOInstituto Oswaldo Cruz, Ministério da SaúdeSaint Louis University Department of Molecular MicrobiologyUniversidade Federal de São Paulo (UNIFESP)Eickhoff, Christopher SGiddings, Olivia KYoshida, Nobuko [UNIFESP]Hoft, Daniel F2015-06-14T13:41:48Z2015-06-14T13:41:48Z2010-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion687-691application/pdfhttp://dx.doi.org/10.1590/S0074-02762010000500015Memórias do Instituto Oswaldo Cruz. Instituto Oswaldo Cruz, Ministério da Saúde, v. 105, n. 5, p. 687-691, 2010.10.1590/S0074-02762010000500015S0074-02762010000500015.pdf0074-0276S0074-02762010000500015http://repositorio.unifesp.br/handle/11600/5853engMemórias do Instituto Oswaldo Cruzinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T01:46:09Zoai:repositorio.unifesp.br/:11600/5853Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T01:46:09Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
title |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
spellingShingle |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection Eickhoff, Christopher S Trypanosoma cruzi mucosal immunity vaccines |
title_short |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
title_full |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
title_fullStr |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
title_full_unstemmed |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
title_sort |
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection |
author |
Eickhoff, Christopher S |
author_facet |
Eickhoff, Christopher S Giddings, Olivia K Yoshida, Nobuko [UNIFESP] Hoft, Daniel F |
author_role |
author |
author2 |
Giddings, Olivia K Yoshida, Nobuko [UNIFESP] Hoft, Daniel F |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Saint Louis University Department of Molecular Microbiology Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Eickhoff, Christopher S Giddings, Olivia K Yoshida, Nobuko [UNIFESP] Hoft, Daniel F |
dc.subject.por.fl_str_mv |
Trypanosoma cruzi mucosal immunity vaccines |
topic |
Trypanosoma cruzi mucosal immunity vaccines |
description |
The potential use of the Trypanosoma cruzi metacyclic trypomastigote (MT) stage-specific molecule glycoprotein-82 (gp82) as a vaccine target has not been fully explored. We show that the opsonization of T. cruzi MT with gp82-specific antibody prior to mucosal challenge significantly reduces parasite infectivity. In addition, we investigated the immune responses as well as the systemic and mucosal protective immunity induced by intranasal CpG-adjuvanted gp82 vaccination. Spleen cells from mice immunized with CpG-gp82 proliferated and secreted IFN-γ in a dose-dependent manner in response to in vitro stimulation with gp82 and parasite lysate. More importantly, these CpG-gp82-immunized mice were significantly protected from a biologically relevant oral parasite challenge. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-08-01 2015-06-14T13:41:48Z 2015-06-14T13:41:48Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0074-02762010000500015 Memórias do Instituto Oswaldo Cruz. Instituto Oswaldo Cruz, Ministério da Saúde, v. 105, n. 5, p. 687-691, 2010. 10.1590/S0074-02762010000500015 S0074-02762010000500015.pdf 0074-0276 S0074-02762010000500015 http://repositorio.unifesp.br/handle/11600/5853 |
url |
http://dx.doi.org/10.1590/S0074-02762010000500015 http://repositorio.unifesp.br/handle/11600/5853 |
identifier_str_mv |
Memórias do Instituto Oswaldo Cruz. Instituto Oswaldo Cruz, Ministério da Saúde, v. 105, n. 5, p. 687-691, 2010. 10.1590/S0074-02762010000500015 S0074-02762010000500015.pdf 0074-0276 S0074-02762010000500015 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Memórias do Instituto Oswaldo Cruz |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
687-691 application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Oswaldo Cruz, Ministério da Saúde |
publisher.none.fl_str_mv |
Instituto Oswaldo Cruz, Ministério da Saúde |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268360150482944 |